Pulmonary transplantation for cystic fibrosis: Pre-transplant recipient characteristics in patients dying of peri-operative sepsis

Journal of Heart and Lung Transplantation

Volumn 22, Issue 7, 2003, Pages 764-769

  De Soyza, Anthony ^a,b   Archer, Linda ^a   Wardle, J ^c   Parry, Gareth ^a   Dark, John H ^a   Gould, Kate ^a   Corris, Paul A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BODY TEMPERATURE; BODY WEIGHT; BURKHOLDERIA CEPACIA; CAUSE OF DEATH; CYSTIC FIBROSIS; DIABETES MELLITUS; DISEASE MARKER; DYING; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMAN; LEUKOCYTE COUNT; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MICROBIOLOGICAL PARAMETERS; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PSEUDOMONAS; RECIPIENT; SEPSIS; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

EID: 0038164802     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(02)00641-1     Document Type: Article

References (13)

1. Kerem E., Reisman J., Corey M., Canny G.J., Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med. 326:(18):1992;1187-1191.
2. Milla C.E., Warwick W.J. Risk of death in cystic fibrosis patients with severely compromised lung function. Chest. 113:(5):1998;1230-1234.
3. Hosenpud J.D., Bennett L.E., Keck B.M., Edwards E.B., Novick R.J. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet. 351:(9095):1998;24-27.
4. Vizza C.D., Yusen R.D., Lynch J.P., Fedele F., Alexander Patterson G., Trulock E.P. Outcome of patients with cystic fibrosis awaiting lung transplantation. Am J Respir Crit Care Med. 162:(3):2000;819-825.
5. Flume P.A. Cystic fibrosis when to consider lung transplantation? Chest. 113:(5):1998;1159-1161.
6. De Meester J., Smits J.M., Persijn G.G., Haverich A. Lung transplant waiting list differential outcome of type of end-stage lung disease, one year after registration . J Heart Lung Transplant. 18:(6):1999;563-571.
7. Hasan A., Corris P.A., Healy M., Wrightson N., Gascoigne A.D., Waller D.A., et al. Bilateral sequential lung transplantation for end stage septic lung disease. Thorax. 50:(5):1995;565-566.
8. Aris R.M., Gilligan P.H., Neuringer I.P., Gott K.K., Rea J., Yankaskas J.R. The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome. Am J Respir Crit Care Med. 155:(5):1997;1699-1704.
9. Chaparro C., Maurer J., Gutierrez C., Krajden M., Chan C., Winton W., et al. Infection with Burkholderia cepacia in cystic fibrosis; outcome following lung transplantation. Am J Repir Crit Care Med. 163:(1):2001;43-48.
10. Egan T.M., Detterbeck F.C., Mill M.R., Gott K.K., Rea J.B., McSweeney J., et al. Lung transplantation for cystic fibrosis effective and durable therapy in a high-risk group . Ann Thorac Surg. 66:(2):1998;337-346.
11. Snell G.I., Bennetts K., Bartolo J., Levvey B., Griffiths A., Williams T., et al. Body mass index as a predictor of survival in adults with cystic fibrosis referred for lung transplantation. J Heart Lung Transplant. 17:(11):1998;1097-1103.
12. De Soyza A., Archer L., McDowell A., Dark J.H., Elborn S., Mahenthiralingam E., et al. Lung transplantation for cystic fibrosis the effect of B cepacia genomovars on post transplant outcomes . Lancet. 358:(9295):2001;1780-1781.
13. LiPuma J.J., Spilker T., Coenye T., Gonzalez C.F. An epidemic Burkholderia cepacia complex strain identified in soil. Lancet. 359:(9322):2002;2002-2003.